Shichun Lu

489 total citations
14 papers, 193 citations indexed

About

Shichun Lu is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Shichun Lu has authored 14 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Shichun Lu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Shichun Lu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Shichun Lu collaborates with scholars based in China, Philippines and Taiwan. Shichun Lu's co-authors include Yusheng Shu, Hongcan Shi, Weiping Shi, Yingwei Pan, Kang Wang, Ying Luo, Tzen‐Yuh Chiang, Shan‐Lu Liu, Mingyi Chen and Ki Ho Hong and has published in prestigious journals such as Advanced Science, Cancer Letters and Medical Physics.

In The Last Decade

Shichun Lu

11 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shichun Lu China 6 80 69 65 64 30 14 193
Zhao-Hai Wang China 9 85 1.1× 35 0.5× 25 0.4× 19 0.3× 46 1.5× 16 204
Fumiyuki Sato Japan 7 29 0.4× 47 0.7× 59 0.9× 36 0.6× 83 2.8× 13 202
Xuehan Zhuang Hong Kong 6 36 0.5× 34 0.5× 34 0.5× 59 0.9× 8 0.3× 10 148
Jiesheng Li China 6 31 0.4× 18 0.3× 67 1.0× 68 1.1× 18 0.6× 9 218
Kuldeep Singh United States 5 24 0.3× 21 0.3× 59 0.9× 104 1.6× 21 0.7× 10 205
Nan-Sheng Cheng China 9 87 1.1× 68 1.0× 40 0.6× 98 1.5× 31 1.0× 17 291
Bingyuan Huang China 7 59 0.7× 31 0.4× 22 0.3× 40 0.6× 6 0.2× 9 193
Yun Xu China 10 104 1.3× 48 0.7× 72 1.1× 133 2.1× 37 1.2× 14 313
Y. Morizane Japan 7 24 0.3× 18 0.3× 30 0.5× 161 2.5× 8 0.3× 9 229
Patricia Stiedl Austria 6 22 0.3× 26 0.4× 27 0.4× 64 1.0× 4 0.1× 8 125

Countries citing papers authored by Shichun Lu

Since Specialization
Citations

This map shows the geographic impact of Shichun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shichun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shichun Lu more than expected).

Fields of papers citing papers by Shichun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shichun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shichun Lu. The network helps show where Shichun Lu may publish in the future.

Co-authorship network of co-authors of Shichun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shichun Lu. A scholar is included among the top collaborators of Shichun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shichun Lu. Shichun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
3.
Zhao, Zhiming, Xuan Zhang, Suxia Sun, et al.. (2025). Robotic hepatopancreatobiliary surgery using the Toumai® system: initial experience and technical considerations from a single center. Updates in Surgery. 77(8). 2183–2189.
4.
Wu, Jun, Yong Chen, Kaiyue Xu, et al.. (2024). 6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. Cancer Letters. 601. 217177–217177. 2 indexed citations
5.
Chen, Yong, Jun Wu, Jie You, et al.. (2024). Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma. Medical Physics. 51(9). 6513–6524. 2 indexed citations
6.
Wang, Xiaolin, Shichun Lu, Chao Sun, et al.. (2021). Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway. Cancer Biology & Therapy. 22(4). 324–332. 12 indexed citations
8.
9.
Lu, Shichun, et al.. (2020). Raddeanin A suppresses lung cancer cell proliferation via induction of apoptosis and increased production of ROS. Cellular and Molecular Biology. 66(7). 174–179. 6 indexed citations
11.
Pan, Yingwei, et al.. (2019). Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis. Surgical Endoscopy. 33(8). 2396–2418. 41 indexed citations
12.
Lu, Shichun, et al.. (2014). Clinical analysis of splenectomy and selective devascularization based on intra-operative free portal pressure. Zhonghua gan-dan waike zazhi. 20(9). 648–651. 1 indexed citations
14.
Lu, Shichun, Ki Ho Hong, Shan‐Lu Liu, et al.. (2002). Genetic variation and population differentiation of Michelia formosana (Magnoliaceae) based on cpDNA variation and RAPD fingerprints: relevance to post-Pleistocene recolonization. Journal of Plant Research. 115(3). 203–216. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026